Dr. Karan Kanhai, MD, PhD, is a physician and medical researcher dedicated to improving the lives of people affected by rare and complex diseases. With more than 20 years of experience in Oncology, Hematology, and orphan-disease drug development, he has worked at the forefront of clinical research to bring new therapies, better diagnostics, and more personalised treatment strategies to patients who often have limited options.

Throughout his career — including senior leadership roles at global pharmaceutical companies — Dr. Kanhai has focused on translating cutting-edge science into meaningful care. He has designed and guided clinical trials for rare cancers and blood disorders, helped shape international treatment programs, and contributed to peer-reviewed research that advances understanding of rare conditions.

Above all, Dr. Kanhai is committed to listening to patients, advocating for their needs, and ensuring that innovation reaches those who need it most. He believes that every person with a rare disease deserves clarity, hope, and access to the best possible care, and he works to make that a reality every day.